Neuland Laboratories has announced revisions to its executive leadership roles, effective April 1, 2026. Mr. Sucheth Rao Davuluri will be re-designated as Executive Vice Chairman, focusing on long-term strategy. Mr. Saharsh Rao Davuluri will assume the role of CEO & Managing Director, overseeing day-to-day operations. These changes aim to support the company’s growth plans and maintain customer trust.
Executive Leadership Changes
Neuland Laboratories has announced modifications to the roles and responsibilities of its executive leadership team, effective April 1, 2026. These changes are designed to align with the company’s growth strategies and ensure a balanced focus on both short-term and long-term objectives.
Sucheth Rao Davuluri’s New Role
Mr. Sucheth Rao Davuluri, currently serving as Vice Chairman & CEO, will be re-designated as Executive Vice Chairman. In this capacity, he will concentrate on strategic areas, including:
- Long-term planning
- Enterprise risk management
- Stakeholder management
- Internal audit oversight
- CSR/philanthropic initiatives through Neuland Foundation
Previously, Mr. Sucheth Rao Davuluri played a crucial role in developing Neuland into a quality-focused API company, expanding from generic APIs to specialty APIs and CDMO services.
Saharsh Rao Davuluri to Lead Operations
Mr. Saharsh Rao Davuluri, currently Vice Chairman & Managing Director, will be re-designated as CEO & Managing Director. He will be responsible for day-to-day operations, utilizing his experience in building the CMS business.
Mr. Saharsh Rao has been instrumental in elevating Neuland to a well-regarded CDMO. This change will enable the organization to better meet its commitments and maintain customer trust.
Transition and Reporting Structure
A transition period will commence immediately and continue until March 31, 2026, to ensure a seamless transfer of operational responsibilities. After this period, the changes will be considered complete, subject to shareholder approval.
Source: BSE
